Cargando...

Neoadjuvant treatment for resectable pancreatic adenocarcinoma

Pancreatic adenocarcinoma is the fourth leading cause of cancer mortality in the United States in both men and women, with a 5-year survival rate of less than 5%. Surgical resection remains the only curative treatment, but most patients develop systemic recurrence within 2 years of surgery. Adjuvant...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Clin Oncol
Autores principales: Wong, John, Solomon, Naveenraj L, Hsueh, Chung-Tsen
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734931/
https://ncbi.nlm.nih.gov/pubmed/26862486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v7.i1.1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!